Eugia Pharma signs voluntary license with Medicines Patent Pool to develop generic version of Nilotinib Capsules
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
This partnership will revolutionize Pharmarack's digital infrastructure with Snowflake's single, integrated platform to facilitate advanced analytic
This patent-pending, high-efficiency chromatography media is used for the purification of novel peptide-based pharmaceuticals in the GLP-1 agonist class including type 2 diabetes and obesity treatments
This trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
The company has now received the Establishment Inspection Report (EIR) indicating closure of the inspection
The randomised, multi-centre, evaluator blinded, parallel group, active controlled Phase 3 trial is being led by Lanhzou Biotechnique Development
The new API plant is set up to meet all domestic and international regulatory standards and will manufacture niche molecules that have a global requirement
Agreement provides customers in the majority of Europe* access to supply through Univar Solutions distribution network
Subscribe To Our Newsletter & Stay Updated